
Current Price | $0.41 | Mkt Cap | $3.6M |
---|---|---|---|
Open | $0.49 | P/E Ratio | -0.02 |
Prev. Close | $0.41 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.39 - $0.54 | Volume | 9,849,088 |
52-Wk Range | $0.09 - $5.97 | Avg. Daily Vol. | 14,350,164 |
Current Price | $0.41 | Mkt Cap | $3.6M |
---|---|---|---|
Open | $0.49 | P/E Ratio | -0.02 |
Prev. Close | $0.41 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.39 - $0.54 | Volume | 9,849,088 |
52-Wk Range | $0.09 - $5.97 | Avg. Daily Vol. | 14,350,164 |
Read the most recent pitches from players about EARS.
Recs
Upcoming phase 3 clinical trial to be released as product for tinnitus and sudden hearing loss. This will be a great for people with inner ear disorders and complications.
Recs
Good news for vulture buyers: This Switzerland-based company stated its TACTT2 trial with Keyzilen(TM) for acute inner ear tinnitus missed its primary efficacy endpoints.
Recs
If the trend continues for the week, this is better than I had originally expected. I was thinking 7 by end of the week, but looks 8
Find the members with the highest scoring picks in EARS.
whatsthepoint (99.88) Score: +288.94
The Score Leader is the player with the highest score across all their picks in EARS.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
risktech | 39.01 | 4/11/2018 |
![]() |
5Y | $1.37 | -68.82% | +74.67% | +143.49 | 0 Comment | |
sikiliza | < 20 | 7/29/2019 |
![]() |
5Y | $2.81 | -84.80% | +52.44% | +137.25 | 0 Comment | |
IdahoInvestor | 99.58 | 7/25/2019 |
![]() |
5Y | $2.70 | -84.18% | +52.98% | +137.16 | 0 Comment | |
KingMR012 | < 20 | 10/9/2018 |
![]() |
5Y | $0.60 | -28.82% | +60.30% | -89.11 | 1 Comment | |
Momentum21 | 34.19 | 9/29/2016 |
![]() |
5Y | $1.74 | -75.45% | +113.06% | -188.51 | 0 Comment | |
superstar2 | 95.93 | 8/18/2016 |
![]() |
5Y | $2.21 | -80.67% | +110.47% | -191.15 | 1 Comment | |
roymarshall | 53.51 | 1/6/2016 |
![]() |
3W | $6.10 | -93.00% | +132.03% | -225.02 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.